Danira Habashy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danira Habashy has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Zakaria Gad
Biochemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo (GUC), Cairo, Egypt
3 shared publications - Rana Ahmed Youness
Molecular Genetics and Biochemistry Department, Faculty of Biotechnology, German International University (GIU), Cairo, Egypt
3 shared publications N. Khater
Biochemistry Dept., GUC - German University in Cairo, Giza, Egypt
2 shared publications- Ahmed Moustafa Mansour
Department of Chemistry, Faculty of Science, Cairo University, Gamma Street, Giza, Cairo 12613, Egypt
1 shared publication - Alaa Zeinhom
Department of Biotechnology, Faculty of Science, Cairo University, Gamma Street, Giza, Cairo 12613, Egypt
1 shared publication - Alyaa Dawoud
The University of North Carolina at Chapel Hill 2 Graduate Curriculum in Genetics and Molecular Biology, Biological and Biomedical Sciences Program, School of Medicine Chapel Hill, North Carolina
1 shared publication
Latest Publications
- Open Access
- 18 January 2024
- Published by MDPI AG in Non-Coding RNA
- Vol. 10 (1) , 7
Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review
Recently, myriad studies have defined the versatile abilities of gasotransmitters and their synthesizing enzymes to play a “Maestro” role in orchestrating several oncological and non-oncological circuits and, thus, nominated them as possible therapeutic targets. Although a significant amount of work has been conducted on the role of nitric oxide (NO) and carbon monoxide (CO) and their inter-relationship in the field of oncology, research about hydrogen sulfide (H2S) remains in its infancy. Recently, non-coding RNAs (ncRNAs) have been reported to play a dominating role in the regulation of the endogenous machinery system of H2S in several pathological contexts. A growing list of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are leading the way as upstream regulators for H2S biosynthesis in different mammalian cells during the development and progression of human diseases; therefore, their targeting can be of great therapeutic benefit. In the current review, the authors shed the light onto the biosynthetic pathways of H2S and their regulation by miRNAs and lncRNAs in various oncological and non-oncological disorders.
- 18 January 2024
- Published by MDPI AG in Non-Coding RNA
- Vol. 10 (1) , 7
Open AccessRole of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review
Recently, myriad studies have defined the versatile abilities of gasotransmitters and their synthesizing enzymes to play a “Maestro” role in orchestrating several oncological and non-oncological circuits and, thus, nominated them as possible therapeutic targets. Although a significant amount of work has been conducted on the role of nitric oxide (NO) and carbon monoxide (CO) and their inter-relationship in the field of oncology, research about hydrogen sulfide (H2S) remains in its infancy. Recently, non-coding RNAs (ncRNAs) have been reported to play a dominating role in the regulation of the endogenous machinery system of H2S in several pathological contexts. A growing list of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are leading the way as upstream regulators for H2S biosynthesis in different mammalian cells during the development and progression of human diseases; therefore, their targeting can be of great therapeutic benefit. In the current review, the authors shed the light onto the biosynthetic pathways of H2S and their regulation by miRNAs and lncRNAs in various oncological and non-oncological disorders.
- 15 September 2022
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 51 (37) , 14041-14048
Cytotoxicity of fac-Mn(CO)3 complexes with a bidentate quinoline ligand towards triple negative breast cancer
Before and after illumination, as well as when it was coupled with the medicine Paclitaxel, the visible-light induced fac-Mn(CO)3 molecule of 8-amino showed interesting cytotoxicity against triple-negative breast cancer.
- 15 September 2022
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 51 (37) , 14041-14048
Cytotoxicity of fac-Mn(CO)3 complexes with a bidentate quinoline ligand towards triple negative breast cancer
Before and after illumination, as well as when it was coupled with the medicine Paclitaxel, the visible-light induced fac-Mn(CO)3 molecule of 8-amino showed interesting cytotoxicity against triple-negative breast cancer.
- 1 October 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S1361
51P A novel crosstalk between pyridoxal 5'-phosphate (PLP)-dependent enzymes, CBS and CSE, modulated by MALAT-1/STAT-3 axis
- 1 October 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S1361
51P A novel crosstalk between pyridoxal 5'-phosphate (PLP)-dependent enzymes, CBS and CSE, modulated by MALAT-1/STAT-3 axis
- 1 March 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S7
14P MALAT-1: A novel LncRNA modulating STAT-3 regulated cystathionine-γ-lyase (CSE) in breast cancer
- 1 March 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S7
14P MALAT-1: A novel LncRNA modulating STAT-3 regulated cystathionine-γ-lyase (CSE) in breast cancer
- Open Access
- 5 December 2018
- Published by IntechOpen
Early Metastasis in Colorectal Cancer Poses an Option for New Diagnostic and Treatment Strategies
Metastasis is the spread of tumor cells from a primary site to a secondary site within the host’s body. It is initiated by the detachment of the tumor cells from the primary tumor followed by invasion into the surrounding tissue. Thereafter the cells migrate across the endothelium and into the blood vessels (intravasation). During the intravasation the cells have to survive the sheer forces and the immune response. Upon arrival to the target organ, the cells leave the circulation and cross the endothelium to reach the host organ. Once there, the tumor cells are greeted with the organ’s local immune cells and with a hostile or inappropriate environment, where they finally have to form proliferating colonies. Metastasis is therefore far from being a straight-forward or efficient process with less than 0.1% of disseminating tumor cells (around 1 × 109 cells per day for a 1 cm size tumor) succeeding in colonizing distal organs. The identification of the involved marker during the early metastasis process will be essential for establishment of new diagnostics tools, as well as development of novel treatment strategies.
- 5 December 2018
- Published by IntechOpen
Open AccessEarly Metastasis in Colorectal Cancer Poses an Option for New Diagnostic and Treatment Strategies
Metastasis is the spread of tumor cells from a primary site to a secondary site within the host’s body. It is initiated by the detachment of the tumor cells from the primary tumor followed by invasion into the surrounding tissue. Thereafter the cells migrate across the endothelium and into the blood vessels (intravasation). During the intravasation the cells have to survive the sheer forces and the immune response. Upon arrival to the target organ, the cells leave the circulation and cross the endothelium to reach the host organ. Once there, the tumor cells are greeted with the organ’s local immune cells and with a hostile or inappropriate environment, where they finally have to form proliferating colonies. Metastasis is therefore far from being a straight-forward or efficient process with less than 0.1% of disseminating tumor cells (around 1 × 109 cells per day for a 1 cm size tumor) succeeding in colonizing distal organs. The identification of the involved marker during the early metastasis process will be essential for establishment of new diagnostics tools, as well as development of novel treatment strategies.